Company: FENC
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111260
Chunk: 4

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 1L
Chunk 4
---
Item 1. Legal Proceedings. 

CIPLA Litigation

On December 1, 2022, we received a letter dated November 30, 2022, notifying us that CIPLA Ltd. and CIPLA USA (“CIPLA”) submitted to the FDA an ANDA (ANDA No. 218028) for a generic version of PEDMARK® (sodium thiosulfate solution) that contained Paragraph IV Certifications on two of our patents covering PEDMARK®: the OHSU licensed ‘190 Patent, expiration date January 2038; and our US 11,291,728 Patent (the “’728 Patent”), expiration date July